Yervoy

Generic name: Ipilimumab
Dosage form: intravenous infusion (50 mg/10 mL, 200 mg/40 mL)
Drug class: Anti-CTLA-4 monoclonal antibodies

Usage of Yervoy

Yervoy (ipilimumab) is a monoclonal antibody used to treat specific cancers including melanoma, non-small cell lung cancer (NSCLC), pleural mesothelioma, esophageal cancer, kidney cancer (RCC), liver cancer, or colorectal cancer.  Yervoy can be used alone or combined with another cancer medicine such as Opdivo (nivolumab).

Yervoy is an immunotherapy that blocks a protein (antigen) that can stop your immune system from working properly and attacking cancer cells. When Yervoy has blocked the protein (CTLA-4) the immune system is able to find and kill the cancer cells. 

Yervoy is from the class of medicines called immune checkpoint inhibitors, and because it blocks the T-lymphocyte antigen 4 (CTLA-4), it is called a CTLA-4 inhibitor. 

Yervoy became an FDA-approved medicine on August 18, 2010, for treating advanced melanoma, and since then, the FDA approval has been extended to include a range of cancers.

Yervoy side effects

Common Yervoy side effects

The most common side effects include:

  • fever, cough, shortness of breath;
  • nausea, vomiting, stomach pain, loss of appetite;
  • diarrhea, constipation;
  • weight loss;
  • hormonal problems;
  • rash or itching;
  • headache, dizziness, tiredness;
  • sleep problems (insomnia); or
  • pain in your muscles, joints, or bones.
  • Serious Yervoy side effects

    Get emergency medical help if you have signs of an allergic Reaction to this medicine (hives, difficulty breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).

    Some side effects may occur during the injection. Tell your caregiver if you feel dizzy, light-headed, short of breath, itchy, tingly, chilled, or feverish.

    Serious and sometimes fatal reactions may occur during treatment with this medicine or months after your last dose. Call your doctor right away if you have symptoms such as:

  • severe or ongoing diarrhea, severe stomach pain, bloody or tarry stools;
  • fever, swollen glands, body aches;
  • new or worsening skin rash, itching, or blistering;
  • painful sores in mouth or nose, throat, or genital area;
  • chest pain, irregular heartbeats;
  • severe muscle weakness, ongoing pain in your muscles or joints;
  • numbness or tingling in your hands or feet;
  • vision problems, eye pain or redness;
  • lung problems - new or worsening cough, chest pain, feeling short of breath;
  • kidney problems - little or no urination, swelling in your feet or ankles, blood in your urine;
  • liver problems - right-sided upper stomach pain, tiredness, bruising or bleeding, dark urine, yellowing of your skin or eyes;
  • signs of a hormonal disorder - frequent or unusual headaches, lack of energy, dizziness, fainting, mood or behavior changes, increased thirst or urination, feeling cold, weight gain, or weight loss; or
  • symptoms of brain swelling - confusion, headache, memory problems, hallucinations, neck stiffness, drowsiness, seizure (convulsions).
  • Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

    This is not a complete list of side effects, and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    Before taking Yervoy

    You should not receive this medicine if you are allergic to the active ingredient ipilimumab or any of the iNACtive ingredients.

    To make sure Yervoy is safe for you, tell your doctor if you have ever HAD:

  • liver problems;
  • an autoimmune disorder (lupus, sarcoidosis, Crohn's disease, ulcerative colitis);
  • an organ transplant or stem cell transplant; or
  • a nerve-muscle disorder, such as myasthenia gravis, or Guillain-Barre syndrome.
  • This medicine is not approved for use by anyone younger than 12 years old and for some types of cancer, it is used only in adults.

    Pregnancy

    Yervoy may harm an unborn baby. 

    You may need to have a negative pregnancy test before starting this treatment. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 3 months after your last dose. Tell your doctor if you become pregnant.

    If you are pregnant, your name may be listed on a pregnancy registry to track the effects of ipilimumab on the baby.

    Breastfeeding

    Do not breastfeed while using this medicine, and for at least 3 months after your last dose.

    Relate drugs

    How to use Yervoy

    Yervoy is given as an infusion into a vein (IV infusion). A healthcare provider will give you this injection.

    This medicine must be given slowly, and the infusion can take 30-90 minutes to complete.

    Yervoy is usually given once every 3 to 6 weeks, Depending on which type of cancer is being treated. Your other cancer medications may be given more often. Your doctor will determine how long to treat you with all medicines.

    Yervoy can be used alone or combined with other cancer medicines such as Opdivo (Nivolumab). 

    You may be given other medications to treat or prevent certain side effects.

    You may need frequent medical tests and your cancer treatments may be delayed based on the results.

    Yervoy is available as an Injection: 50 mg/10 mL (5 mg/mL) or 200 mg/40 mL (5 mg/mL) in a single-dose vial. 

    Warnings

    Serious and sometimes fatal reactions may occur during treatment with this medicine or months after your last dose. Call your doctor at once if you have: chest pain, cough, shortness of breath, vision changes, severe muscle pain or weakness, diarrhea and severe stomach pain, blood in your stools, little or no urinating, swelling, bruising or bleeding, dark urine, yellowing of the skin or eyes, confusion, hallucinations, a seizure, skin blistering, or a hormonal disorder (frequent headaches, feeling light-headed, increased thirst or urination, feeling cold, weight gain or loss).

    Before you receive Yervoy, tell your doctor if you have liver damage, an autoimmune disorder such as lupus or sarcoidosis, Crohn's disease, ulcerative colitis, or if you have received an organ transplant.

    Tell your doctor if you are pregnant or plan to become pregnant while using this medicine.

    What other drugs will affect Yervoy

    Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. 

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords